National Trends in Aspirin Use and Expenditures in the United States: Analysis of The Medical Expenditure Panel Survey 2000-2021.

ABSTRACT:

Introduction

Since its invention in 1897, aspirin (ASA) has been the most widely used and cost-effective antiplatelet agent to prevent and treat atherosclerotic cardiovascular disease (ASCVD). We aimed to study the trends and expenditures associated with ASA use in the USA.

Methods

We conducted a serial cross-sectional analysis using the Medical Expenditure Panel Survey data from January 2000 to December 2021, focusing on adults aged ≥ 40 years. Total and out-of-pocket expenditures associated with ASA were estimated to 2021 US dollars (USD). Trends, demographics, and predictors of ASA use among patients with and without ASCVD were also evaluated.

Results

A total of 53 million adults were identified during the study period. The number of ASA users increased from 2.9 mi

SUBMITTER: Thyagaturu H 

PROVIDER: S-EPMC11607373 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature